Tubular La Ribonucleoprotein 7 Suppresses TGF-β/SMAD3 Signaling and Attenuates Kidney Fibrogenesis
Journal of the American Society of Nephrology · 2026
DOI: 10.1681/asn.0000001084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026. Verfasst von Ziyu Zhao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National …. Hauptthemen laut MEDLINE: Smad3 Protein, Kidney Tubules, Ribonucleoproteins, Autoantigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Guangzhou Science and Technology Plan Project, the Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University.
Abstract (Originalsprache)
Key Points LARP7 suppresses TGF- β /SMAD3–driven fibrosis by sequestering CDK9, which inhibits SMAD3 T179 phosphorylation and profibrotic transcription. TGF- β 1 represses LARP7 expression in injured tubules, establishing a self-reinforcing loop that amplifies and sustains fibrogenic signaling. Tubule-specific LARP7 restoration interrupts this vicious cycle, attenuates SMAD3 activity, and confers protection against kidney fibrosis in vivo .
Background
TGF- β 1/SMAD3 signaling drives organ fibrosis, underscoring the need to identify its endogenous regulators for precision therapies. LARP7, a core component of the 7SK snRNP complex that sequesters cyclin-dependent kinase 9, has an unexplored role in kidney fibrosis and a potential interplay with TGF- β /SMAD3 signaling.
Methods
Single-cell and spatial transcriptomic analyses combined with immunostaining of human kidney biopsies were used to investigate the association between LARP7 and TGF- β /SMAD3 signaling in patients with CKD. In vivo and in vitro models evaluated the expression profile of LARP7 after insults and its contribution to TGF- β /SMAD3 signaling and fibrosis postinjury.
Results
We demonstrated that LARP7, abundantly expressed in normal tubules, was downregulated in CKD patients and inversely correlated with TGF- β /SMAD3 activation. This expression pattern was conserved across ischemic, toxic, and obstructive fibrosis models and recapitulated in TGF- β 1–treated tubular epithelial cells, indicating a general link between LARP7 downregulation and enhanced TGF- β /SMAD3 signaling. Further loss-of-function and gain-of-function in vitro studies confirmed that LARP7 acted as a specific disruptor of SMAD3 linker region (T179) phosphorylation—an event that coincided with C -terminal phosphorylation and amplified SMAD3 transcriptional activity. LARP7 mediated this by sequestering CDK9 within the 7SK snRNP, thereby preventing CDK9–SMAD3 interaction and consequently inhibiting SMAD3 T179 phosphorylation and profibrotic transcription. TGF- β 1 itself suppressed LARP7 expression, completing a self-reinforcing feedback loop that perpetuates TGF- β /SMAD3 signaling in injured tubular epithelial cells. Further in vivo studies showed that tubule-specific Larp7 deletion exacerbated kidney fibrosis after ischemic injury, whereas its overexpression, either preventatively (prefibrosis in an obstructive model) or therapeutically (postfibrosis in ischemic and toxic models), attenuated functional decline and halted fibrotic progression.
Conclusions
Our findings revealed tubular LARP7 as a key negative regulator of TGF- β /SMAD3–driven kidney fibrogenesis. Targeted overexpression of LARP7 in injured tubular epithelial cells attenuated TGF- β 1/SMAD3 signaling and conferred protection against postinjury fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong…
- Department of Nephrology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
ORCID-Profile: Zhuoyu Zhou, Ansheng Cong, Zhijie Huang, Zhichen Yang, Jie Zhu, Zuoyu Hu, Jinjin Li, Fan Fan Hou, Wei Cao
Förderung
- National Natural Science Foundation of China
- Guangzhou Science and Technology Plan Project
- the Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University
- Program of Introducing Talents of Discipline to Universities, 111 Plan
- Key Technologies R&D Program of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Zhao, Z., Zhou, Z., Cong, A., Su, C., Chen, Q., Huang, Z., Liu, J., Yang, Z., Zhu, J., Hu, Z., Yuan, L., Li, J., Zhou, Z., Cai, Y., Zhang, W., Hou, F. F., & Cao, W. (2026). Tubular La Ribonucleoprotein 7 Suppresses TGF-β/SMAD3 Signaling and Attenuates Kidney Fibrogenesis. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000001084
Vancouver
Zhao Z, Zhou Z, Cong A, Su C, Chen Q, Huang Z, et al. Tubular La Ribonucleoprotein 7 Suppresses TGF-β/SMAD3 Signaling and Attenuates Kidney Fibrogenesis. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000001084
BibTeX
@article{Zhao2026,
author = {Zhao, Ziyu and Zhou, Zhuoyu and Cong, Ansheng and Su, Cailing and Chen, Qiuyi and Huang, Zhijie and Liu, Jiachen and Yang, Zhichen and Zhu, Jie and Hu, Zuoyu and Yuan, Lujuan and Li, Jinjin and Zhou, Zhanmei and Cai, Yanran and Zhang, Wang and Hou, Fan Fan and Cao, Wei},
title = {Tubular La Ribonucleoprotein 7 Suppresses TGF-β/SMAD3 Signaling and Attenuates Kidney Fibrogenesis},
journal = {Journal of the American Society of Nephrology},
year = {2026},
doi = {10.1681/asn.0000001084}
}
EUVIMED